In a regulatory filing, the company said, “Officers of Elevance Health (ELV) expect to speak with investors and analysts over the next week. During these meetings, company officers will reaffirm adjusted shareholders’ earnings for full year 2026 to be at least $25.50 per diluted share. The company also will reaffirm its 2026 benefit expense ratio guidance of 90.2% plus or minus 50 basis points.”
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELV:
- Myomo, Elevance agree to contract for multi-state network participation
- The Week That Was, The Week Ahead: Macro and Markets, Mar. 8
- Elevance Health reaffirms FY26 adjusted EPS of at least $25.50, consensus $26.05
- Elevance Health Restructures Leadership, Reaffirms 2026 Guidance
- Elevance Health CFO to expand responsibilities to include oversight of Carelon